Form 4: Achieve Life Sciences Director Receives Stock Grant
Insider Transaction (Form 4)
Aaron Royston, a Director of Achieve Life Sciences, Inc., reported multiple transactions in common stock on July 27, 2026.
Summary
- Grant/award: acquired 25,000 Stock Option (right to buy) on July 27, 2026; holds 25,000 after (Direct).
- Grant/award: acquired 16,700 Restricted Stock Unit (RSU) on July 27, 2026; holds 16,700 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Aaron Royston — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Stock Option (right to buy) | 25,000 | — | — | 25,000 |
| 2026-07-27 | Grant/award | Restricted Stock Unit (RSU) | 16,700 | — | — | 16,700 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (25,000 shares) |
| 2026-07-27 | Grant/award (16,700 shares) |
Keywords
insider transaction, Form 4, ACHV, ACHIEVE LIFE SCIENCES, INC., neutral, Aaron Royston
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.